Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

Gut microbiota / Evidence-based microbiome knowledge (incl. AI chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Ezetimibe

Welcome to meRfi-GM!

Please register to continue your trial period!

meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Ezetimibe acts by decreasing cholesterol absorption in the small intestine and lowers plasma cholesterol levels

Clostridium XVIII and Lachnospiracea incertae sedis were negatively correlated with total cholesterol (TC) and LDL-C after ezetimibe intervention
Jin et al. 2021b Front. Pharmacol. 12: 732541

In contrast, TG, total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) were signiﬁcantly decreased by ezetimibe
Jin et al. 2021b Front. Pharmacol. 12: 73254…

References (Sources)

Distinctive Gut Microbiota in Patients with Overweight and Obesity with Dyslipidemia and its Responses to Long-term Orlistat and Ezetimibe Intervention: A Randomized Controlled Open-label Trial
Jin et al. 2021b Front. Pharmacol. 12: 732541
The Effect of Orlistat and Ezetimibe, Alone or in Combination, on Serum LDL and Small Dense LDL Cholesterol Levels in Overweight and Obese Patients with Hypercholesterolaemia
Nakou et al. 2008 Curr. Med. Res. Opin. 24(7): 1919-1929

AI Chat

2/26/2026

Chat with our artificial intelligence:

Start chat!

Ezetimibe

Welcome to meRfi-GM!

Navigation

Contents

References (Sources)

AI Chat

Links